Interleukin-5 Antagonist [EPC] - N0000191872
Pharmacologic Class Information
Pharmacologic Code | N0000191872 |
Pharmacologic Name | Interleukin-5 Antagonist |
Pharmacologic Uses |
|
Pharmacologic Concept | Established Pharmacologic Classes - [EPC] |
Pharmacologic Concept Description | An established pharmacologic class is a term or phrase that is scientifically valid
and clinically meaningful according to the following definitions:
|
NDC Products with Interleukin-5 Antagonist
The table contains 4 products whose active ingredient are classified under the same pharmacologic class Interleukin-5 Antagonist [EPC].
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
---|---|---|---|---|---|---|---|
0173-0881 | Nucala | Non-Proprietary Name: Mepolizumab | Injection, Powder, For Solution | Subcutaneous | Glaxosmithkline Llc | ACTIVE | |
0173-0892 | Nucala | Non-Proprietary Name: Mepolizumab | Injection, Solution | Subcutaneous | Glaxosmithkline Llc | ACTIVE | |
0173-0904 | Nucala | Non-Proprietary Name: Mepolizumab | Injection, Solution | Subcutaneous | Glaxosmithkline Llc | ACTIVE | |
59310-610 | Cinqair | Non-Proprietary Name: Reslizumab | Injection, Solution, Concentrate | Intravenous | Teva Respiratory, Llc | ACTIVE |